The China healthcare industry is ranked the second largest in the world behind the US and is growing at a consistently rapid rate. The third webinar in Swecare's series focusing on the Chinese healthcare market will discuss various options for market entry and offer first-hand insights from two Swedish companies that recently have ventured into the market.
Representatives of Nordic Match, financial advisors to Calmark, will cover various strategies for entering the Chinese life science and healthcare market, such as partnerships, JV, inbound M&A, direct investments and licensing.
08:30 – 08:35 Welcome and Introduction
Anna Riby – Swecare
08:35 – 09:05 What are the different strategic routes to consider when entering China?
Markus Dahlström, Partner, and Tony Wang, Partner, Nordic Match
09:05 - 09:15 Story-sharing from Calmark's China journey
Anna Söderlund, CEO, Calmark
09:15 – 09:25 Story-sharing from Vironova's China journey
Mohammed Homman, CEO, Vironova
09:25 – 09:45 Q&A, discussion and summary
Read more and register here. Participation is free.